Related references
Note: Only part of the references are listed.Estimation of Breast Cancer Overdiagnosis in a US Breast Screening Cohort
Marc D. Ryser et al.
ANNALS OF INTERNAL MEDICINE (2022)
Prognostic selection and long-term survival analysis to assess overdiagnosis risk in lung cancer screening randomized trials
Eugenio Paci et al.
JOURNAL OF MEDICAL SCREENING (2021)
Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention Trial
Sandra Gonzalez Maldonado et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Overdiagnosis in lung cancer screening
Matthew E J Callister et al.
Lancet Respiratory Medicine (2021)
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography Modeling Study for the US Preventive Services Task Force
Rafael Meza et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis
John K. Field et al.
LANCET REGIONAL HEALTH-EUROPE (2021)
Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial
Nikolaus Becker et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Smoking Cessation in the ITALUNG Lung Cancer Screening: What Does Teachable Moment Mean?
Francesco Pistelli et al.
NICOTINE & TOBACCO RESEARCH (2020)
Fine particulate matter constituents and cause-specific mortality in China: A nationwide modelling study
Jun Yang et al.
ENVIRONMENT INTERNATIONAL (2020)
Overdiagnosis of lung cancer with low-dose computed tomography screening: meta-analysis of the randomised clinical trials
John Brodersen et al.
BREATHE (2020)
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
U. Pastorino et al.
ANNALS OF ONCOLOGY (2019)
Life-Gained-Based Versus Risk-Based Selection of Smokers for Lung Cancer Screening
Li C. Cheung et al.
ANNALS OF INTERNAL MEDICINE (2019)
Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial
Denise R. Aberle et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening An Official American Thoracic Society Research Statement
M. Patricia Rivera et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive A Microsimulation Study
Tanner J. Caverly et al.
ANNALS OF INTERNAL MEDICINE (2018)
Accounting for the Harms of Lung Cancer Screening
Mark H. Ebell et al.
JAMA INTERNAL MEDICINE (2018)
Estimation of Overdiagnosis of Lung Cancer in Low-Dose Computed Tomography Screening: A Secondary Analysis of the Danish Lung Cancer Screening Trial
Bruno Heleno et al.
JAMA INTERNAL MEDICINE (2018)
Lung Cancer Screening in a Safety-Net Hospital: Implications of Screening a Real-World Population versus the National Lung Screening Trial
Jonathan M. Iaccarino et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
The impact of overdiagnosis on the selection of efficient lung cancer screening strategies
Summer S. Han et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial
Eugenio Paci et al.
THORAX (2017)
Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies
Roman Gulati et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling
Mathilde M. W. Wille et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography
Maurizio Infante et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Overdiagnosis in lung cancer screening: why modelling is essential
Kevin ten Haaf et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2015)
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods
Jamie L. Carter et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods
Jamie L. Carter et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement
Virginia A. Moyer
ANNALS OF INTERNAL MEDICINE (2014)
Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial
Anthony B. Miller et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Edward F. Patz et al.
JAMA INTERNAL MEDICINE (2014)
Selection Criteria for Lung-Cancer Screening
Martin C. Tammemaegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The benefits and harms of breast cancer screening: an independent review
M. G. Marmot et al.
LANCET (2012)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Overdiagnosis in Cancer
H. Gilbert Welch et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting
C. Kastner et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2006)
Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis
PM Marcus et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Measuring explained variation in linear mixed effects models
RH Xu
STATISTICS IN MEDICINE (2003)